Cancer Health Disparities

Here has been substantial progress in cancer treatment, screening, diagnosis, and prevention over the past several decades, addressing cancer health disparities—such as higher cancer death rates, less frequent use of proven screening tests, and higher rates of advanced cancer diagnoses—in certain populations is an area in which progress has not kept pace.

These disparities are frequently seen in people from low-socioeconomic groups, certain racial/ethnic populations, and those who live in geographically isolated areas.

Documented cancer health disparities include: A higher incidence of a particularly aggressive form of breast cancer (the triple-negative subtype) among African American women than women of other racial/ethnic groups

substantially higher rates of prostate cancer incidence and death among African American men than men of other racial/ethnic groups

higher rates of kidney cancer among American Indian and Alaska Natives than other racial/ethnic groups. Higher rates of liver cancer among Asian and Pacific Islanders than other racial/ethnic groups

higher rates of cervical cancer incidence and death among Hispanic and African American women than women of other racial/ethnic groups. Many of the same population groups that experience cancer health disparities are also significantly underrepresented in cancer clinical trials.

There has been some recent evidence of progress against cancer health disparities, including reductions in lung and prostate cancer deaths among African American men over the past decade. But researchers and public health officials agree that progress has come too slowly, and the cost of disparities—in terms of premature deaths, lost productivity, and the impact on communities—remains substantial and must be addressed. Cancer disparities and equity research is needed to understand why some groups of people may be more or less likely to develop cancer, experience cancer-related health problems, or die from cancer than other groups of people.

    Related Conference of Cancer Health Disparities

    March 27-28, 2023

    4th Global Summit on Oncology and Hematology

    London, UK
    April 26-27, 2023

    4th International Summit on Cancer & Chemotherapy

    San Diego, USA
    May 02-03, 2023

    13th World Congress on Breast Cancer

    London, UK
    May 08-09, 2023

    5th Asia Pacific Oncology and Cancer Conference

    Zurich, Switzerland
    May 08-09, 2023

    43rd Euro Congress on Cancer Science & Therapy

    Zurich, Switzerland
    June 05-06, 2023

    6th Euro Oncology and Cancer Summit

    Valencia, Spain
    June 05-06, 2023

    8th World Conference on Breast and Cervical Cancer

    Valencia, Spain
    June 12-13, 2023

    13th World Congress on Breast Cancer Research & Therapies

    Melbourne, Australia
    June 19-20, 2023

    11th World Summit on Cancer Science and Oncology

    Vienna, Austria
    July 19-20, 2023

    42nd World Cancer Conference

    Zurich, Switzerland
    July 24-25, 2023

    10th World Congress on Epigenetics and Chromosome

    Amsterdam, Netherlands
    July 27-28, 2023

    6th International Conference on Women Oncology

    Vancouver, Canada
    August 23-24, 2023

    23rd World Congress on Cancer and Diagnostics

    Toronto, Canada
    September 07-08, 2023

    7th Global Meeting on Oncology and Radiology

    Paris, France
    September 18-19, 2023

    4th World Congress on Breast Cancer

    Rome, Italy
    September 21-22, 2023

    15th Annual Conference on Cancer Research

    Kualalumpur, Malaysia
    October 04-05, 2023

    8th Global Summit on Cancer Science and Oncology

    Barcelona, Spain
    November 15-16, 2023

    36th Conference on Preventive Oncology and Diagnostic Cancer

    Edinburgh, Scotland

    Cancer Health Disparities Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in